Publications
114
Citations
3,148
Est. group size
—
Recurring co-author estimate
Active years
48
Publishing since 1978
George H. Hinkle's work focuses on radiopharmaceuticals — radioactive compounds used in nuclear medicine for imaging and diagnosing disease, including cancer such as prostate cancer. His publications also address practical and regulatory aspects of nuclear medicine practice, such as guidelines for radiopharmaceutical use, sterile compounding standards, and monoclonal antibody-based imaging agents.
Publication output has been low and irregular over the past decade, with occasional single papers in most years and no publications in several years, averaging less than one paper per year recently.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- The SNMMI/ACNM Practice Guideline for the Use of Radiopharmaceuticals 5.0
Journal of Nuclear Medicine Technology · 2025
- <sup>51</sup>Cr Red Blood Cells in the Study of Hematologic Disease: A Historical Review
Journal of Nuclear Medicine Technology · 2024
- Radiopharmaceuticals
ASHP eBooks · 2023
- USP General Chapter <825> Impact on Nuclear Medicine Technology Practice
Journal of Nuclear Medicine Technology · 2020
- Chapter 33: Therapeutic Applications of Radioactive Agents
2020
- 13 Radiopharmaceuticals as Compounded Sterile Preparations
American Society of Health-System Pharmacists eBooks · 2017
- Journal of Nuclear Medicine Technology×3
- American Society of Health-System Pharmacists eBooks×1
- ASHP eBooks×1
- Shuang Liu
Medicine · Purdue University West Lafayette
- Qi‐Huang Zheng
Medicine · Indiana University
- Jyoti Roy
Medicine · Purdue University West Lafayette
- Edward W. Martin
Medicine · The Ohio State University
- Kai Chen
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile